TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

Higher-Dose Of Wegovy Demonstrates Weight Loss And Cardiovascular Benefits

Benzinga Logo Benzinga By Vandana Singh
Higher-Dose Of Wegovy Demonstrates Weight Loss And Cardiovascular Benefits

Novo Nordisk presented new findings from the STEP UP trial showing Wegovy helps obese people lose an average of 21% body weight and achieve cardiovascular health improvements with both 2.4 mg and 7.2 mg doses.

Insights
B   neutral

Mentioned as previous employer of Katy Grant, with no specific positive or negative context


NVO   positive

Demonstrated significant clinical trial results for weight loss drug, showing potential for expanded treatment options and improved patient outcomes with both current and investigational drug doses